Literature DB >> 11351936

Repeated self-administered cocaine "binges" in rats: effects on cocaine intake and withdrawal.

N H Mutschler1, H E Covington, K A Miczek.   

Abstract

RATIONALE: Repeated access to cocaine may engender behavioral sensitization, which emerges as an enhanced response to the effects of cocaine. Repeated exposure to prolonged self-administration sessions has been shown to produce an escalation in cocaine intake.
OBJECTIVE: The objective of the present study was to identify the consequence of repeated exposure to prolonged access to self-administered cocaine.
METHODS: Pairs of rats that were matched for training, housing, and surgery were treated as a single experimental unit, and these pairs were separated into groups for two separate experiments. In the first experiment, one animal of the pair acquired and maintained a stable rate for i.v. cocaine self-administration (0.5 mg/infusion), while the second rat was yoked such that it passively received saline infusions in the same pattern. After acquisition, the active self-administration rats were given free access to cocaine for 16 h (binge), while the yoked animal continued to receive infusions of saline. Twenty-four hours after the binge, both animals were exposed to tactile startle stimuli, and ultrasonic vocalizations (USVs) and startle reflexes were measured. The animals were exposed to three cocaine binges and 24 h post-binge startle tests with an interval of 10 days between binges, and then a fourth binge, with an interval of 24 h separating binges three and four. In the second experiment, pairs of rats were separated into three groups (A, B, and C). The active cocaine rats acquired self-administration and were allowed access to a 16-h cocaine binge while their yoked controls received saline. Twenty-four hours after the binge, all animals were tested for emission of USVs and startle reflexes with an identical protocol as that in experiment 1. Immediately after exposure to the startle stimuli, the self-administering animals were again allowed to self-administer cocaine for either 16 (group A), 12 (group B), or 8 h (group C).
RESULTS: In experiment 1, the total amount of cocaine self-administered was significantly decreased when the cocaine binges were separated by 10 days, but total cocaine intake during the binge significantly increased when the drug-free interval was 24 h. The pattern of self-administration and the withdrawal response remained unchanged over consecutive binges. In experiment 2, rats that self-administered cocaine for either 16 or 12 h emitted significantly less USVs immediately after renewed access than they emitted 24 h after the first access period.
CONCLUSION: It appeared that consecutive prolonged self-administration was insufficient to produce sensitization, as measured by cocaine intake and renewed access to self-administered cocaine was sufficient to reduce the large number of USVs that characterize withdrawal from a cocaine binge.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11351936     DOI: 10.1007/s002130000646

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats.

Authors:  Richard M Allen; Linda A Dykstra; Regina M Carelli
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

2.  Cocaine-seeking behavior after extended cocaine-free periods in rats: role of conditioned stimuli.

Authors:  Svetlana Semenova; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

3.  Large conductance voltage- and Ca2+-gated potassium (BK) channel β4 subunit influences sensitivity and tolerance to alcohol by altering its response to kinases.

Authors:  Cristina Velázquez-Marrero; Garrett E Seale; Steven N Treistman; Gilles E Martin
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

4.  Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats.

Authors:  Yu Liu; David C S Roberts; Drake Morgan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-14       Impact factor: 4.530

5.  Variability of drug self-administration in rats.

Authors:  Leigh V Panlilio; Jonathan L Katz; Roy W Pickens; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2003-03-18       Impact factor: 4.530

6.  Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats.

Authors:  Richard M Allen; Kristina A Uban; Elizabeth M Atwood; David S Albeck; Dorothy J Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-07-21       Impact factor: 3.533

7.  Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Drake Morgan; Mark A Smith; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

8.  The effects of social contact on cocaine intake under extended-access conditions in male rats.

Authors:  Andrea M Robinson; Ryan T Lacy; Justin C Strickland; Charlotte P Magee; Mark A Smith
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

9.  Individual differences in anhedonic and accumbal dopamine responses to chronic social stress and their link to cocaine self-administration in female rats.

Authors:  Akiko Shimamoto; Elizabeth N Holly; Christopher O Boyson; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2014-09-03       Impact factor: 4.530

10.  NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking.

Authors:  Herbert E Covington; Thomas F Tropea; Anjali M Rajadhyaksha; Barry E Kosofsky; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2007-12-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.